International Clinical Trial: An IL-1 inhibitor combined with compound betamethasone as first-line therapy for acute gouty arthritis: an open-label, single-arm, exploratory cinical trial

Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600121829) titled 'An IL-1 inhibitor combined with compound betamethasone as first-line therapy for acute gouty arthritis: an open-label, single-arm, exploratory cinical trial' on April 3.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Henan Provincial Hospital of Traditional Chinese Medicine

Condition: acute gouty arthritis

Recruitment Status: Not Recruiting

Phase: 4

Date of First Enrollment: 2026-04-21

Target Sample Size: Experimental group:43;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=314024

Published by HT Digital Content Service...